Experience

Focus Care Pharmaceuticals B.V.

• Netherlands
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• • Jan 2022 - Present

  Responsible for adding new generic medicinal products with added value to the pipeline, activities include market analysis, negotiating contract details, account management of suppliers and coordinating the progress of new products until market launch. Main tasks and responsibilities:- Preparation of market analysis in order to draft a business case;- Account management of new and active suppliers;- Project management of new products from start until product launch;- Main contact point for internal and external stakeholders for launch projects; - Member of the scientific board for marketing activities; Show less

• • Jun 2020 - Jan 2022

  Responsible for the medical and scientific preparations, execution, evaluation and registration of clinical research in order to extend the product portfolio. In addition, I perform the role as project leader for new products to accelerate timely product launch. Main tasks and responsibilities:- Preparation of clinical studies in collaboration with CRO’s and investigators;- Building relationships with consultants, principal clinical investigators and collaborators;- Design and management of project planning and timelines using MS project;- Serve as a main contact point for medical-scientific advice for the internal organisation;- Manage project budget for clinical research strategy; Show less



Catalyze Group

• Netherlands
• Business Consulting and Services
• 1 - 100 Employee

• Consultant life sciences

  • Jun 2017 - May 2020

  Supporting innovative life sciences innovations and entrepreneurs in healthcare and biotechnology to reach their full potential. As consultant I prepare complex funding applications, manage the application process in collaboration with Catalyze clients and colleagues, and take the lead in applications prepared by consultant sub teams. Main tasks and responsibilities: - Writing complex funding applications (e.g. H2020, Eurostars); - Design of project ideas towards a successful project proposal; - Composition of project consortiums for complex projects; - Organize and chair project meetings; - Serve as main contact point for internal and external stakeholders; - Manage timelines for efficient and timely submission of funding applications; - Support and training of junior consultants. Show less



UMCG

• Netherlands
• Hospitals and Health Care
• 700 & Above Employee

• PhD student

  • Dec 2011 - May 2018

  Promoter: Prof. Dr. E.A.A. Nollen and Prof. Dr. A. de Bruin Title: The molecular role of SERF2 in development and misfolded protein aggregation Summary: Age-related neurodegenerative diseases such as Alzheimer’s disease are characterized by protein aggregates in the brain. SERF2 has been identified as enhancer of protein aggregation in human cell models for diseases. The aim was to unravel the endogenous function of SERF2 by identifying its physiological function during embryogenesis and establish its role in the amyloid-beta pathology in Alzheimer’s disease using a mouse model for disease. Publications: Stroo E*, Janssen J*, Sin O, Hogewerf W, Koster M, Harkema L, Youssef, S.A. Beschorner N, Wolters A, Bakker B, Becker L, Garrett L, Marschall S, Holter S, Wurst W, Fuchs H, Gailus-Durner V, de Angelis MH, Thathiah A, Foijer F, Van de Sluis B, Van Deursen J, Jucker M, De Bruin A, Nollen EAA. Deletion of SERF2 in mice delays embryonic development and alters amyloid deposit structure in the brain (2023). Manuscript accepted in Life sience alliance Pras A, Houben B, Aprile, FA, Seinstra R, Gallardo R, Janssen L, Hogewerf H, Gallrein C, De Vleeschouwer M, Mata Cabana A, Koopman M, Stroo E, de Vries M, Edwards S, Kirstein J, Vendruscolo M, Falsone FS, Rousseau, Schymkowitz, Nollen EAA (2021). The cellular modifier MOAG-4/SERF drives amyloid formation through charge cluster complementation. EMBO Journal. 40(21):e107568 Sin O, de Jong T, Mata-Cabana A, Kudron M, Zaini A, Aprile FA, Seinstra R, Stroo E, Prins RW, Martineau C, Wang HH, Hogewerf W, Steinhof A, Wanker EE, Vendruscolo M, Calkhoven CF, Reinke V, Guryev V, Nollen EAA (2017) Identification of an RNA polymerase III regulator linked to disease-associated protein aggregation. Molecular Cell. 65(6): 1096-1108 Stroo E., Koopmans M., Nollen E.A.A., Mata-Cabana A. (2017) Cellular regulation of amyloid formation in aging and disease. Frontiers in Neuroscience 11(64). Show less



Massachusetts General Hospital

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Intern

  • Jan 2011 - Aug 2011



Amsterdam UMC

• Netherlands
• Hospitals and Health Care
• 700 & Above Employee

• Intern

  • Feb 2010 - Jul 2010

  Publication: Espitia Pinzon N, Stroo E, ‘t Hart BA, Bol JGJM, Drukarch B, Bauer J, van Dam AM (2014) Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter. PLOS ONE 9(6) Publication: Espitia Pinzon N, Stroo E, ‘t Hart BA, Bol JGJM, Drukarch B, Bauer J, van Dam AM (2014) Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter. PLOS ONE 9(6)



Vrije Universiteit Amsterdam (VU Amsterdam)

• Netherlands
• Higher Education
• 700 & Above Employee

• Intern

  • Oct 2008 - Mar 2009